How I treat advanced Hodgkin lymphoma — a global view-Reference-Cited by-同舟云学术

How I treat advanced Hodgkin lymphoma — a global view

Published:2020-06-19 Issue:6 Volume:190 Page:837-850
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Hokland Peter¹,Shah Mansi²,David Kevin²,Evens Andrew²,Auer Rebecca³,Ledieu Rifca⁴,Kreissl Stefanie⁵,Bröckelmann Paul J.⁵,Borchmann Peter⁵,Korula Anu⁶,Mathews Vikram⁶,Owattanapanich Weerapat⁷,Trotman Judith⁸

Affiliation:

1. Department of Clinical Medicine Faculty of Health Aarhus University Aarhus Denmark

2. Division of Blood Disorders Rutgers Cancer Institute of New Jersey New Brunswick NJ USA

3. Department of Haemato‐oncology Barts Health NHS Trust LondonUK

4. Centre for Haemato‐oncology Barts Cancer Institute London UK

5. German Hodgkin Study Group Department I of Internal Medicine Center for Integrated Oncology University of CologneAachen Bonn Cologne Duesseldorf Köln Germany

6. Department of Haematology Christian Medical College Vellore India

7. Division of Hematology Department of Medicine Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand

8. Haematology Department Concord Repatriation General Hospital University of Sydney Sydney Australia

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16587

Reference61 articles.

1. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

2. 18F-FDG PET/CT bone/bone marrow findings in Hodgkin’s lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging

3. Fertility preservation after chemotherapy for Hodgkin lymphoma

4. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

5. von Tresckow B. Comparison of first‐line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma;Skoetz N;Cochrane Database Syst Rev.,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of standard BEACOPP regimen versus ABVD regimen for treatment of advanced Hodgkin’s lymphoma;Journal of Cancer Research and Therapeutics;2024-08

2. Harnessing multi-source data for individualized care in Hodgkin Lymphoma;Blood Reviews;2024-05

3. Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial;Journal of Clinical Oncology;2024-01-01

4. Rounding off our Global View series;British Journal of Haematology;2023-11

5. Cost-effectiveness of response-adapted therapy (RAT) for advanced Hodgkin’s Lymphoma compared with conventional treatment in India: a Markov-model based analysis;Leukemia & Lymphoma;2023-09-05